Subchondral Bone Explained: What It Does and Why It Can Hurt
The bone right beneath your cartilage has its own blood supply and its own nerves. Here's what researchers know about it, what they don't, and where a joint supplement realistically fits.
Subchondral bone is the layer of bone directly under joint cartilage. Unlike cartilage, it has blood vessels and nerves, and in one MRI study of 401 people with knee osteoarthritis, about 78% of those with knee pain had lesions in it. Researchers still disagree about whether those bone changes start the damage or follow it.
What subchondral bone actually is
Look at the end of a thigh bone and you'll find a glossy cap of cartilage. Underneath it sits bone, and the top layer of that bone is called subchondral bone, which just means "below the cartilage." It comes in two parts. A thin, dense plate lies right against the cartilage. Beneath the plate is spongy trabecular bone that keeps remodeling for as long as you're alive (Bone Research, 2021).
The plate is threaded with blood vessels and nerve fibers. The cartilage above it has neither. So when a knee hurts under load, the cartilage isn't the tissue sending the message. Pain has to come from somewhere else in the joint, and bone is one of the candidates.
Joint marketing talks about the coating almost exclusively. The pan is what carries the load, and it's the part with the wiring. That doesn't make the bone guilty in every sore knee. It means the bone belongs in the conversation.
Section 02
What happens to the bone when a joint is overloaded
Bone adapts to the loads it carries, which is normally a good thing. Trouble starts when the load turns abnormal: an old ligament injury, years of hard impact, a joint that doesn't track well, extra body weight. Researchers describe a sequence that begins in the bone itself.
- Turnover in the subchondral bone speeds up
- New blood vessels and nerve fibers grow toward the cartilage
- Microdamage appears in the bone and in the calcified cartilage above it
- Marrow lesions, thought to be edema, can show up on MRI
Sources: Bone Research (2021); Arthritis Research & Therapy (2013); Annals of Internal Medicine (2001).
The timing is where it gets interesting. The 2021 review notes that lesions in the bone can appear before the cartilage visibly breaks down. In the same paper, the authors say the exact role of subchondral bone in starting osteoarthritis is unclear. Both statements are true at once, and a page that hands you a cleaner story than that is tidying up the science.
| Stage | Subchondral plate | Bone beneath it | What it means |
|---|---|---|---|
| Early | Thinner and more porous | Lower density, thinner struts | Microdamage begins and cartilage starts to break down (Arthritis Research & Therapy, 2013) |
| Late | Thickened and hardened (sclerosis) | More bone volume and density, but under-mineralized | Denser isn't stronger. Reported gains run about 15% in bone mineral density and up to 30% in bone volume, with lower material stiffness (Frontiers in Cell and Developmental Biology, 2020) |
That's why "weak bones cause arthritis" is too tidy. Under an arthritic joint the bone can be thin early on and dense but poorly mineralized later, and neither state is the same thing as having osteoporosis.
Section 03
Bone marrow lesions and knee pain
of people with painful knee osteoarthritis had a bone marrow lesion on MRI, compared with 30% of people whose knees didn't hurt. (Felson et al., 2001, Annals of Internal Medicine)
Felson's team ran that study in 2001. It was one of the earliest to look at bone marrow lesions in osteoarthritis, and the numbers still stand out. Here's what they did and, just as important, what they couldn't tell us.
401 people with knee osteoarthritis on X-ray, average age 66.8, drawn from Veterans Affairs clinics and the community. 351 had knee pain and 50 didn't. Each person had an MRI of one knee, and the researchers scored the size of any bone marrow lesion.
It was a snapshot, not a follow-up. It can't say whether lesions cause pain, whether painful knees get loaded differently and grow lesions as a result, or whether both simply travel with more advanced arthritis. Lesions did get more common as X-ray severity rose, which makes that third possibility hard to wave away.
- Lesions in 77.5% of the painful group (272 of 351) against 30% of the pain-free group (15 of 50)
- Large lesions in 35.9% of the painful group against 2% of the pain-free group
- Lesion frequency climbed with X-ray grade, from 48% at the mildest grade to 100% at the most severe
There's a plausible wiring story behind the association. A 2022 mini review from Melbourne researchers pulls together evidence that sensory neurons supplying bone can signal pain and become sensitized in osteoarthritis. Plausible, again, isn't proven.
Section 04
What the research hasn't shown yet
Here's the part most joint supplement pages skip. We looked, and we haven't found a trial showing that glucosamine, MSM, hyaluronic acid, boswellia or curcumin shrinks a bone marrow lesion or rebuilds subchondral bone.
What those trials do measure is pain, stiffness, physical function and blood markers of inflammation. A 2025 meta-analysis pooled 21 randomized trials of curcumin in knee osteoarthritis, and its authors flagged high variation in regimens, control groups and disease grade. One small pilot of a branded boswellia extract reported changes on X-ray, including joint gap and bone spurs. That's a measurement at the edge of the joint, not a look at the bone under the cartilage.
The only supplement trial we found with MRI bone-lesion outcomes tested vitamin D. Fifty people took 800 IU a day for two years, and lesion volume didn't differ significantly from placebo (Perry et al., 2019). Vitamin D isn't in Joint Axis Pro. We mention it because it's the closest thing to a supplement test of the bone-lesion idea, and it didn't show an effect.
Section 05
Where Joint Axis Pro fits
Joint Axis Pro isn't a bone product, and we don't sell it as one. It's a 6 in 1 formula built around the parts of the joint a supplement can plausibly support: cartilage building blocks, lubrication and the everyday inflammatory response.
Glucosamine sulfate is the building block for cartilage structure. Hyaluronic acid supports the synovial fluid that lubricates the joint, and MSM is a sulfur compound used for connective tissue support. Boswellia serrata extract and curcumin extract sit on the inflammatory side, both traditionally used to support a balanced response and everyday joint comfort. Black pepper extract (piperine) is in there to improve absorption of the others, curcumin especially.
If your pain is coming mainly from the bone, a supplement like this is unlikely to be the whole answer. You should know that before you buy anything.
Section 06
When to see a clinician instead of shopping
Some knee pain isn't a supplement question at all.
- The pain started suddenly, especially after a fall or a twist
- The joint is hot, red or visibly swollen
- The knee locks or gives way
- The pain is getting worse, or wakes you at night
- You take prescription medication, a blood thinner for example, and want to add a supplement. Ask your prescriber or pharmacist first
Section 07
People also ask
Clinical evidence
What the research says
Section 08
Frequently asked questions
References
Sources
- Felson DT et al. (2001). The association of bone marrow lesions with pain in knee osteoarthritis. Annals of Internal Medicine, 134(7):541-549.
- Bone marrow lesions in osteoarthritis: characterising genetic and histological changes (PubMed Central review). Secondary source for lesion frequency by X-ray grade in the Felson cohort.
- Johns Hopkins Arthritis Center: news summary of the Felson 2001 study (source for the large-lesion percentages).
- Bone Research (2021). Subchondral bone microenvironment in osteoarthritis and pain.
- Arthritis Research & Therapy (2013). Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes.
- Frontiers in Cell and Developmental Biology (2020). Subchondral bone remodeling: a therapeutic target for osteoarthritis.
- Morgan M et al. (2022). Mini review on innervation of subchondral bone in osteoarthritis pain. Frontiers in Endocrinology.
- Perry TA et al. (2019). Effect of vitamin D supplementation on synovial tissue volume and subchondral bone marrow lesion volume in symptomatic knee osteoarthritis. BMC Musculoskeletal Disorders, 20:76.
- BMC Complementary Medicine and Therapies (2025). Effects of curcumin on serum inflammatory biomarkers in patients with knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.
- Pilot randomized, double-blind, placebo-controlled trial of a branded Boswellia serrata extract in knee osteoarthritis (48 participants, 120 days). Open access via PubMed Central.
- Abrams GD, Harris JD, Cole BJ. Subchondral Bone Treatment. In: Biologic Knee Reconstruction: A Surgeon's Guide (CRC Press). Source for sclerosis and cysts being visible on plain X-ray.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider, particularly if you have a diagnosed joint condition, take blood thinners or other prescription medications, or are pregnant or nursing.
Joint Axis Pro: 6 in 1 Joint Support
A 6 in 1 joint support supplement with glucosamine sulfate, MSM, hyaluronic acid, boswellia, curcumin and black pepper extract, formulated to support cartilage, joint lubrication and everyday comfort. 120 capsules, a 30-day supply.
Shop Joint Axis Pro →